The increase in the number of individuals susceptible to macular degeneration is expected to help the market capture maximum shares in the coming years. About 11 million people in the U.S. have some form of age-related macular degeneration, according to the Bright Focus Foundation. Additionally, this number will double to nearly 22 million by 2050, …